Enalaprilat
Spezifikationen
76420-72-9CAS-Nummer
278-459-3EG-Nummer
(2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acidIUPAC-Name
C18H24N2O5Chemische Formel
348.4 g/molMolekulargewicht
Enalaprilat; 76420-72-9; Enalaprilate; Enalaprilatum; Enalapril diacid; Enalaprilat anhydrous; enalaprilat (anhydrous); N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline; Q508Q118JM; MK 422; CHEBI:4786; N-(1(S)-Carboxy-3-phenylpropyl)-L-alanyl-L-proline; NSC-760053; (2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid; L-Proline, N-((1S)-1-carboxy-3-phenylpropyl)-L-alanyl-; L-Proline, N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-; CHEBI:59877; Enalapril diacid dihydrate anhydrous; N-((1S)-1-carboxy-3-phenylpropyl)-L-alanyl-L-proline; (2S)-1-((2S)-2-(((2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)pyrrolidine-2-carboxylic acid; RefChem:136738; MK422; 278-459-3; Enalapril diacid dihydrate; GV0O7ES0R3; Vasotec i.v.; Enalapril acid; Enalaprilic acid; (S)-1-((S)-2-(((S)-1-Carboxy-3-phenylpropyl)amino)propanoyl)pyrrolidine-2-carboxylic acid; Enalaprilat [INN]; DTXSID0048975; MK-422; MFCD00865786; 1-((2S)-2-{[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO}PROPANOYL)-L-PROLINE; ((S)-1-carboxy-3-phenylpropyl)-L-alanyl-L-proline; (2S)-1-[(2S)-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}propanoyl]pyrrolidine-2-carboxylic acid; EAL; DTXCID301265905; ENALAPRILAT INHIBITOR; SMR000466359; CAS-76420-72-9; enalaprilat [Spanish]; MK 421 diacid; CHEMBL577; Enalaprilate [French]; Enalaprilatum [Latin]; UNII-Q508Q118JM; NCGC00183129-01; (2S)-1-((2S)-2-(((1S)-1-CARBOXY-3-PHENYLPROPYL)AMINO)PROPANOYL)PYRROLIDINE-2-CARBOXYLIC ACID; (2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid; EINECS 278-459-3; Enalaprilate; Enalaprilic acid; MK 421 diacid; SCHEMBL37289; MLS000759476; MLS001424138; BIDD:GT0752; GTPL6332; orb1908989; Enalaprilat, analytical standard; Enalapril Maleate EP Impurity C; HY-B0231A; HMS2051H16; HMS2089P04; HMS2232B19; HMS3263O13; Pharmakon1600-01503833; Tox21_113430; Tox21_501036; BDBM50367254; EBC-26684; NSC760053; T6340L; AKOS015840130; AKOS015892570; Tox21_113430_1; CCG-101042; DB09477; LP01036; NC00292; SDCCGSBI-0633781.P001; NCGC00164593-01; NCGC00164593-02; NCGC00164593-11; NCGC00261721-01; AS-13013; BP-41163; CS-0012359; E1302; NS00015409; EN300-123964; AB00698268-05; AB00698268-07; AB00698268-08; AB00698268_09; AB00698268_10; ENALAPRIL DIACID DIHYDRATE ANHYDROUS [MI]; ENALAPRIL MALEATE IMPURITY C [EP IMPURITY]; F600817; SR-01000763426; Q5375179; SR-01000763426-3; BRD-K99447003-335-02-5; BRD-K99447003-335-03-3; BRD-K99447003-335-04-1; BRD-K99447003-335-05-8; N-[(s)-1-carboxy-3-phenyl-propyl]-l-alanyl-l-proline; 1-(N-((S)-1-CARBOXY-3-PHENYLPROPYL)-L-ALANYL)-L-PROLINE; L-Proline, 1-(N-(1-carboxt-3-phenylpropyl)-L-alanyl)-, (S)-; L-PROLINE, 1-(N-(1-CARBOXY-3-PHENYLPROPYL)-L-ALANYL)-, (S)-; (S)-1-((S)-2-(((S)-1-Carboxy-3-phenylpropyl)amino)propanoyl)pyrrolidine-2-carboxylicacid; (2S)-1-[(2S)-2-[[(1S)-1-CARBOXY-3-PHENYL-PROPYL]AMINO]PROPANOYL]PYRROLIDINE-2-CARBOXYLIC ACID; (2S)-1-[(2S)-2-[[(1S)-1-Carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic Acid (Enalaprilat)Synonyme
